| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.2 | 0.0007 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 0.0008 |